Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Meredith J. Aull"'
Autor:
Ayman Al Jurdi, Esther C. Liu, Thalia Salinas, Meredith J. Aull, Michelle Lubetzky, Alexander L. Drelick, Catherine B. Small, Sandip Kapur, Choli Hartono, Thangamani Muthukumar
Publikováno v:
Frontiers in Nephrology, Vol 2 (2022)
BackgroundKidney transplantation in HIV-infected individuals with end-stage kidney disease is associated with improved survival compared to dialysis. Rabbit anti-thymocyte globulin (rATG) induction in HIV-infected kidney transplant recipients has bee
Externí odkaz:
https://doaj.org/article/efc10ce84b32427c909a32c2178761a4
Autor:
Cheguevara Afaneh, Barrie S. Rich, Meredith J. Aull, Choli Hartono, David B. Leeser, Sandip Kapur
Publikováno v:
Journal of Transplantation, Vol 2011 (2011)
Introduction. Pancreas transplantation (PTx) is the only definitive intervention for type 1 diabetes. Medical advancements in diabetes care have led to an aging PTx candidate pool. We report our experience with patients ≥50 years of age undergoing
Externí odkaz:
https://doaj.org/article/b1c0b86c0f0943c18e032c3db4eccc32
Autor:
Esther C Liu, Meredith J. Aull, Choli Hartono, Shawn Mazur, Jun Lee, Angela Loo, Samuel Sultan, Jennifer H. Lee, Thangamani Muthukumar
Publikováno v:
Kidney International Reports
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients
Autor:
Brittany T. Abel, Samuel Sultan, Sandip Kapur, John R. Lee, Thalia Salinas, Meredith J. Aull, Darshana Dadhania, Rebecca Craig-Schapiro, Michelle Lubetzky
Publikováno v:
American Journal of Transplantation
The COVID‐19 pandemic has brought unprecedented challenges to the transplant community. The reduction in transplantation volume during this time is partly due to concerns over potentially increased susceptibility and worsened outcomes of COVID‐19
Autor:
Thalia Salinas, Zoe Kapur, Jehona Marku-Podvorica, Meredith J. Aull, John R. Lee, Rebecca Craig-Schapiro, Sophie Rand, Shady Albakry, Zhen Zhao, Darshana Dadhania, Nataliya Hauser, Michelle Lubetzky, Vijay K. Sharma, Sandip Kapur, Ashely Sukhu, Samuel Sultan, Melissa M. Cushing
The response of the immune system to COVID-19 in end stage kidney disease patients who undergo kidney transplantation has yet to be described. We report data on 72 patients who underwent SARS-CoV-2 antibody testing both before and after kidney transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2104e67454522680a9bdf5e91759b6c
https://doi.org/10.1101/2021.07.25.21261066
https://doi.org/10.1101/2021.07.25.21261066
Autor:
Meredith J. Aull, Mona D. Doshi, Rohini Prashar, Sumit Mohan, Emmanuel Edusei, Eric Sherman, Demetra Tsapepas, Darshana Dadhania
Publikováno v:
Clinical Transplantation
The COVID‐19 pandemic brought living donor kidney transplant programs across the United States to a near halt in March 2020. As programs have begun to reopen, potential donor candidates often inquire about their risk of a COVID‐19 infection and i
Autor:
Sandip Kapur, Anthony C. Watkins, Caitlin Finn, Rebecca Craig-Schapiro, Meredith J. Aull, Samuel Sultan, Joseph J. Del Pizzo
Publikováno v:
Journal of endourology. 35(7)
Introduction: Kidney transplant candidates are occasionally found during the pre-transplant evaluation to have a suspicious mass in a native kidney. Further work-up and management of such a mass may delay transplantation for several months, which may
Autor:
Sandip Kapur, Samuel Sultan, Meredith J. Aull, Jun Lee, John R. Lee, Jehona Marku-Podvorica, Laura F Gingras, Stuart D. Saal, Darshana Dadhania, Manikkam Suthanthiran, Michelle Lubetzky, Thalia Salinas, Rebecca Craig-Schapiro, Thangamani Muthukumar, Choli Hartono, Rosy Priya Kodiyanplakkal
Publikováno v:
Nephrology Dialysis Transplantation
Background Kidney graft recipients receiving immunosuppressive therapy may be at heightened risk for coronavirus disease 2019 (Covid-19) and adverse outcomes. It is therefore important to characterize the clinical course and outcome of Covid-19 in th
Autor:
Meredith J. Aull, Brittany Barnaba, Kenneth E. Sherman, Meghan E. Sise, Jenna L. Gustafson, Peter P. Reese, Raymond T. Chung, Adele Rike-Shields, Robert S. Brown, J. Richard Landis, E. Steve Woodle, Silas P. Norman, Caitlin Phillips, John J. Friedewald, Stacey Prenner, Robert J. Fontana, Mona D. Doshi, Dianne S. Belshe, Douglas E. Schaubel, Niraj M. Desai, Winfred W. Williams, Rita R. Alloway, David S. Goldberg, Jens Kort, Samuel Sultan, Christine M. Durand, Nahel Elias, Melissa Fernando, Josh Levitsky
Publikováno v:
J Am Soc Nephrol
Background Single-center trials and retrospective case series have reported promising outcomes using kidneys from donors with hepatitis C virus (HCV) infection. However, multicenter trials are needed to determine if those findings are generalizable.
Autor:
Jehon Marku-Podvorica, Jun Lee, Rebecca Craig-Shapiro, Darshana Dadhania, Samuel Sultan, Stuart D. Saal, Meredith J. Aull, Laura F Gingras, Choli Hartono, Thangamani Muthukumar, Manikkam Suthanthiran, John R. Lee, Sandip Kapur, Rosy Priya Kodiyanplakkal, Michelle Lubetzky
BackgroundOrgan graft recipients receiving immunosuppressive therapy are likely to be at heightened risk for the Coronavirus Disease 2019 (Covid-19) and adverse outcomes including death. It is therefore important to characterize the clinical course a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c51a614c3cac5d3a1717786fda3dfbd